About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Companion Diagnostics Market Size to reach 15.87 Billion by 2032
Companion Diagnostics Market
Companion Diagnostics Market

Companion Diagnostics Market Size, Share & Trends Analysis Report By Technology (Polymerase Chain Reaction (PCR) , Next-generation Sequencing (NGS), Immunohistochemistry, In Situ Hybridization, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Central Nervous System Disorders, Virology Diseases, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH946DR
Last Updated : Feb 01, 2024
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Companion Diagnostics Market, By Technology (2022-2032)
    1. Polymerase Chain Reaction (PCR) 
    2. Next-generation Sequencing (NGS)
    3. Immunohistochemistry
    4. In Situ Hybridization
    5. Others
  2. Companion Diagnostics Market, By Indication (2022-2032)
    1. Oncology
    2. Autoimmune Diseases
    3. Cardiovascular Diseases
    4. Central Nervous System Disorders
    5. Virology Diseases
    6. Others
    1. North America
      1. North America Companion Diagnostics Market, By Technology
        1. Polymerase Chain Reaction (PCR) 
          1. Next-generation Sequencing (NGS)
            1. Immunohistochemistry
              1. In Situ Hybridization
                1. Others
                2. North America Companion Diagnostics Market, By Indication
                  1. Oncology
                    1. Autoimmune Diseases
                      1. Cardiovascular Diseases
                        1. Central Nervous System Disorders
                          1. Virology Diseases
                            1. Others
                            2. U.S.
                              1. U.S. Companion Diagnostics Market, By Technology
                                1. Polymerase Chain Reaction (PCR) 
                                  1. Next-generation Sequencing (NGS)
                                    1. Immunohistochemistry
                                      1. In Situ Hybridization
                                        1. Others
                                        2. U.S. Companion Diagnostics Market, By Indication
                                          1. Oncology
                                            1. Autoimmune Diseases
                                              1. Cardiovascular Diseases
                                                1. Central Nervous System Disorders
                                                  1. Virology Diseases
                                                    1. Others
                                                  2. Canada
                                                2. Europe
                                                  1. Europe Companion Diagnostics Market, By Technology
                                                    1. Polymerase Chain Reaction (PCR) 
                                                      1. Next-generation Sequencing (NGS)
                                                        1. Immunohistochemistry
                                                          1. In Situ Hybridization
                                                            1. Others
                                                            2. Europe Companion Diagnostics Market, By Indication
                                                              1. Oncology
                                                                1. Autoimmune Diseases
                                                                  1. Cardiovascular Diseases
                                                                    1. Central Nervous System Disorders
                                                                      1. Virology Diseases
                                                                        1. Others
                                                                        2. U.K.
                                                                          1. U.K. Companion Diagnostics Market, By Technology
                                                                            1. Polymerase Chain Reaction (PCR) 
                                                                              1. Next-generation Sequencing (NGS)
                                                                                1. Immunohistochemistry
                                                                                  1. In Situ Hybridization
                                                                                    1. Others
                                                                                    2. U.K. Companion Diagnostics Market, By Indication
                                                                                      1. Oncology
                                                                                        1. Autoimmune Diseases
                                                                                          1. Cardiovascular Diseases
                                                                                            1. Central Nervous System Disorders
                                                                                              1. Virology Diseases
                                                                                                1. Others
                                                                                              2. Germany
                                                                                              3. France
                                                                                              4. Spain
                                                                                              5. Italy
                                                                                              6. Russia
                                                                                              7. Nordic
                                                                                              8. Benelux
                                                                                              9. Rest of Europe
                                                                                            2. APAC
                                                                                              1. APAC Companion Diagnostics Market, By Technology
                                                                                                1. Polymerase Chain Reaction (PCR) 
                                                                                                  1. Next-generation Sequencing (NGS)
                                                                                                    1. Immunohistochemistry
                                                                                                      1. In Situ Hybridization
                                                                                                        1. Others
                                                                                                        2. APAC Companion Diagnostics Market, By Indication
                                                                                                          1. Oncology
                                                                                                            1. Autoimmune Diseases
                                                                                                              1. Cardiovascular Diseases
                                                                                                                1. Central Nervous System Disorders
                                                                                                                  1. Virology Diseases
                                                                                                                    1. Others
                                                                                                                    2. China
                                                                                                                      1. China Companion Diagnostics Market, By Technology
                                                                                                                        1. Polymerase Chain Reaction (PCR) 
                                                                                                                          1. Next-generation Sequencing (NGS)
                                                                                                                            1. Immunohistochemistry
                                                                                                                              1. In Situ Hybridization
                                                                                                                                1. Others
                                                                                                                                2. China Companion Diagnostics Market, By Indication
                                                                                                                                  1. Oncology
                                                                                                                                    1. Autoimmune Diseases
                                                                                                                                      1. Cardiovascular Diseases
                                                                                                                                        1. Central Nervous System Disorders
                                                                                                                                          1. Virology Diseases
                                                                                                                                            1. Others
                                                                                                                                          2. Korea
                                                                                                                                          3. Japan
                                                                                                                                          4. India
                                                                                                                                          5. Australia
                                                                                                                                          6. Singapore
                                                                                                                                          7. Taiwan
                                                                                                                                          8. South East Asia
                                                                                                                                          9. Rest of Asia-Pacific
                                                                                                                                        2. Middle East and Africa
                                                                                                                                          1. Middle East and Africa Companion Diagnostics Market, By Technology
                                                                                                                                            1. Polymerase Chain Reaction (PCR) 
                                                                                                                                              1. Next-generation Sequencing (NGS)
                                                                                                                                                1. Immunohistochemistry
                                                                                                                                                  1. In Situ Hybridization
                                                                                                                                                    1. Others
                                                                                                                                                    2. Middle East and Africa Companion Diagnostics Market, By Indication
                                                                                                                                                      1. Oncology
                                                                                                                                                        1. Autoimmune Diseases
                                                                                                                                                          1. Cardiovascular Diseases
                                                                                                                                                            1. Central Nervous System Disorders
                                                                                                                                                              1. Virology Diseases
                                                                                                                                                                1. Others
                                                                                                                                                                2. UAE
                                                                                                                                                                  1. UAE Companion Diagnostics Market, By Technology
                                                                                                                                                                    1. Polymerase Chain Reaction (PCR) 
                                                                                                                                                                      1. Next-generation Sequencing (NGS)
                                                                                                                                                                        1. Immunohistochemistry
                                                                                                                                                                          1. In Situ Hybridization
                                                                                                                                                                            1. Others
                                                                                                                                                                            2. UAE Companion Diagnostics Market, By Indication
                                                                                                                                                                              1. Oncology
                                                                                                                                                                                1. Autoimmune Diseases
                                                                                                                                                                                  1. Cardiovascular Diseases
                                                                                                                                                                                    1. Central Nervous System Disorders
                                                                                                                                                                                      1. Virology Diseases
                                                                                                                                                                                        1. Others
                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                      1. LATAM Companion Diagnostics Market, By Technology
                                                                                                                                                                                        1. Polymerase Chain Reaction (PCR) 
                                                                                                                                                                                          1. Next-generation Sequencing (NGS)
                                                                                                                                                                                            1. Immunohistochemistry
                                                                                                                                                                                              1. In Situ Hybridization
                                                                                                                                                                                                1. Others
                                                                                                                                                                                                2. LATAM Companion Diagnostics Market, By Indication
                                                                                                                                                                                                  1. Oncology
                                                                                                                                                                                                    1. Autoimmune Diseases
                                                                                                                                                                                                      1. Cardiovascular Diseases
                                                                                                                                                                                                        1. Central Nervous System Disorders
                                                                                                                                                                                                          1. Virology Diseases
                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                            2. Brazil
                                                                                                                                                                                                              1. Brazil Companion Diagnostics Market, By Technology
                                                                                                                                                                                                                1. Polymerase Chain Reaction (PCR) 
                                                                                                                                                                                                                  1. Next-generation Sequencing (NGS)
                                                                                                                                                                                                                    1. Immunohistochemistry
                                                                                                                                                                                                                      1. In Situ Hybridization
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                        2. Brazil Companion Diagnostics Market, By Indication
                                                                                                                                                                                                                          1. Oncology
                                                                                                                                                                                                                            1. Autoimmune Diseases
                                                                                                                                                                                                                              1. Cardiovascular Diseases
                                                                                                                                                                                                                                1. Central Nervous System Disorders
                                                                                                                                                                                                                                  1. Virology Diseases
                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                              Related Reports

                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                              Clinical Diagnostics Market Size The global clinical diagnostics market size was valued at USD 84.18 billion in 2024 and is projected to reach from USD 98.21 billion in 2025 to USD 187.78 billion by 2033, exhibiting a CAGR of 6.48% during the f
                                                                                                                                                                                                                              Buy Now
                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                              The global COVID-19 diagnostics market was valued at USD 84500 million in 2020 and is expected to grow at 3.2% CAGR during the forecast period. In 2019, a new coronavirus strain was identified to have caused a disease outbreak originating in Wuhan,
                                                                                                                                                                                                                              Buy Now
                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                              The global sepsis diagnostics market size was valued at USD 685 million in 2022. It is expected to reach USD 1,427.44 million by 2031 at a CAGR of 8.5% during the projected period (2023–2031). Factors such as increasing prevalence of
                                                                                                                                                                                                                              Buy Now
                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                              TB Diagnostics Market Size & Trends The global TB diagnostics market size was valued at USD 1.33 billion in 2021 and it is projected to reach a valuation of USD 2.14 billion by 2030 growing at a CAGR of 5.56% during the forecast period (2022–203
                                                                                                                                                                                                                              Buy Now
                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                              The global transplant diagnostics market size was valued at USD 3,550 million in 2019 and is expected to grow with a CAGR of 7.4% during the forecast period, 2020–2029. Organ transplantation is a surgical procedure of removing healthy org
                                                                                                                                                                                                                              Buy Now

                                                                                                                                                                                                                              Purchase Benefits

                                                                                                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                                                                                                              • Completely customizable scope
                                                                                                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                                                                                                              • Dedicated account manager
                                                                                                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                                                                                                              • Permission to print the report

                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                              www.straitsresearch.com
                                                                                                                                                                                                                              © Copyright . All rights Reserved.